Genetic profiling of epidermolysis bullosa in a large Brazilian cohort
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Vanessa Kiyomi Ota und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Division, Department of Morphology and Genetics, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. Hauptthemen laut MEDLINE: Epidermolysis Bullosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: Illumina, DEBRA.
Abstract (Originalsprache)
Background
Epidermolysis bullosa (EB) comprises a diverse group of rare genetic skin fragility disorders. Accurate diagnosis and genetic counselling require genetic analysis. To our knowledge, this is the largest genetic study of EB in Brazil and one of the largest worldwide.
Objectives
To characterize the genetic basis of EB in a large, diverse cohort and provide a comprehensive overview of the mutational landscape in this population.
Methods
Whole-exome sequencing was performed on 393 individuals from 349 families with a clinical or suspected diagnosis of EB.
Results
A definitive EB diagnosis or differential diagnosis was achieved in 91.6% (n = 360/393) of our sample, including 1 case of peeling skin syndrome 2. We identified 211 pathogenic or likely pathogenic variants in 12 genes, including 63 novel variants. Dystrophic EB was the most prevalent type (n = 266/359, 74.1%), with 149 variants identified (46 novel). The most frequent variant was the COL7A1 c.6527_6528insC. EB simplex accounted for 18.7% of cases (n = 67/359), with 36 variants identified (9 novel). The most frequent variants affected residue 125 of KRT14. Junctional EB comprised 6.7% of cases (n = 24/359), with 22 variants (8 novel) identified. The LAMB3 c.31dup variant was the most prevalent. Kindler EB was diagnosed in 0.6% of the patients (n = 2/359), and 4 variants were identified. For 164 of the 359 individuals (45.7%), the initial clinical diagnosis differed from the genetically confirmed EB type, highlighting the importance of genetic diagnosis.
Conclusions
This study provides a comprehensive genetic overview of EB in Brazil, highlighting EB type prevalence and novel variants. This knowledge is crucial for genetic counselling, clinical management and the use of targeted therapies, and potentially benefits patients globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Genetics Division, Department of Morphology and Genetics, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
- Postgraduate Program in Genetics and Molecular Biology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
- DEBRA Brasil (Epidermolysis Bullosa Research Association of Brazil), Brazil.
- Our Lady of Glory State Children's Hospital, Vitória, Brazil.
- Faculty of Medicine, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
- Department of Genetics, National Institute of Science and Technology of Population Medical Genetics (INaGeMP), Porto Alegre, Brazil.
ORCID-Profile: Vanessa Kiyomi Ota
Förderung
- Illumina
- DEBRA
Zitieren
APA
Ota, V. K., Mariath, L. M., Torrelio, R. M. F., Arashiro, C. S., Schuler-Faccini, L., Fernandes, J. M., Rossi, L. L., Magno, J. A., & Martin, P. K. M. (2025). Genetic profiling of epidermolysis bullosa in a large Brazilian cohort. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf303
Vancouver
Ota VK, Mariath LM, Torrelio RMF, Arashiro CS, Schuler-Faccini L, Fernandes JM, et al. Genetic profiling of epidermolysis bullosa in a large Brazilian cohort. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf303
BibTeX
@article{Ota2025,
author = {Ota, Vanessa Kiyomi and Mariath, Luiza Monteavaro and Torrelio, Rosalie Matuk Fuentes and Arashiro, Carolina Sayuri and Schuler-Faccini, Lavínia and Fernandes, Juliene Matos and Rossi, Leandro Leitoguinho and Magno, Jeanine Aparecida and Martin, Priscila Keiko Matsumoto},
title = {Genetic profiling of epidermolysis bullosa in a large Brazilian cohort},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf303}
}
EUVIMED